Afrigen partners with Bio-Sourcing to make drugs in genetically engineered goats
Bio-Sourcing invented the technology that underpins its biotherapeutic platform BioMilk, which uses the goats to express human proteins in their milk
05 June 2024 - 13:27
SA biotech company Afrigen Biologics has signed an agreement with Belgian firm Bio-Sourcing to manufacture medicines in the milk of genetically engineered goats — a move aimed at providing African patients with more affordable treatments for diseases ranging from cancer to diabetes.
Medicines made in living organisms such as white blood cells or enzymes are known as biopharmaceuticals and include products such as monoclonal antibodies and insulin...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.